The integrated products will provide a seamless workflow for interpreting next-generation sequence data from alignment through pathway analysis.
Based on the Global Proteome Machine Database, the tool helps with identification of genomic variants that affect protein post-translational modification sites.
The analysis published by Charles Beagrie reports an approximately £20 million return on investment to the scientific community for every £1 million invested.
The grant will support the day-to-day running, maintenance, and care of the supercomputer through the year 2020.
Both companies have made their products available on Azure, and Curoverse is collaborating with Microsoft on benchmarking tools for analysis pipelines.
In Nature this week: weighting scheme increases GWAS power, and more.
Marc Tessier-Lavigne is to be the next president of Stanford University.
Walgreens has given Theranos 30 days to fix its lab issues, the Wall Street Journal reports.
Journals and research funding agencies pledge to enable the sharing of Zika virus research.
This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.